Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Atea Pharmaceuticals, Inc. | Chief Financial Officer, Executive Vice President, Legal and Secretary | Common Stock | 670K | $2.58M | $3.84 | Feb 1, 2024 | Direct |
Atea Pharmaceuticals, Inc. | Chief Financial Officer, Executive Vice President, Legal and Secretary | Restricted Stock Units | 88.7K | $341K | $3.85 | Jan 31, 2024 | Direct |
Atea Pharmaceuticals, Inc. | Chief Financial Officer, Executive Vice President, Legal and Secretary | Stock Option (Right to Buy) | 200K | Jan 31, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AVIR | Atea Pharmaceuticals, Inc. | Jan 31, 2024 | 4 | -$60.9K | 4 | Feb 2, 2024 | Chief Financial Officer, Executive Vice President, Legal and Secretary |
AVIR | Atea Pharmaceuticals, Inc. | Jan 31, 2023 | 2 | $0 | 4 | Feb 2, 2023 | Chief Financial Officer, Executive Vice President, Legal and Secretary |
AVIR | Atea Pharmaceuticals, Inc. | Jan 31, 2022 | 1 | $0 | 4 | Feb 2, 2022 | Chief Financial Officer, Executive Vice President, Legal and Secretary |